GLENMEDE TRUST CO NA – Regeneron Pharmaceuticals, Inc. Transaction History
GLENMEDE TRUST CO NA portfolio value:
$64.06M
portfolio value
GLENMEDE TRUST CO NA quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.03% | -8.12K shares | 4.29M | $688.87 | 93.00K |
| Q2 2022 | share | Increase | +1.40% | 1.39K shares | -9.87M | $591.13 | 101.12K |
| Q1 2022 | share | Increase | +11.69% | 10.43K shares | 13.26M | $698.42 | 99.73K |
| Q4 2021 | share | Increase | +0.67% | 596 shares | 2.71M | $642.51 | 89.29K |
| Q3 2021 | share | Decrease | -0.37% | -330 shares | 3.95M | $605.18 | 88.69K |
| Q2 2021 | share | Decrease | -2.53% | -2.31K shares | 6.51M | $558.54 | 89.02K |
| Q1 2021 | share | Decrease | -14.62% | -15.64K shares | -8.46M | $473.14 | 91.34K |
| Q4 2020 | share | Decrease | -2.01% | -2.19K shares | -9.43M | $483.11 | 106.98K |
| Q3 2020 | share | Decrease | -3.81% | -4.32K shares | -9.66M | $559.78 | 109.17K |
| Q2 2020 | share | Increase | +3.24% | 3.55K shares | 29.50M | $623.65 | 113.49K |
| Q1 2020 | share | 0.00% | 0 shares | 0 | $488.29 | 109.93K | |
| Q4 2019 | share | Decrease | -48.32% | -102.80K shares | -17.73M | $375.48 | 109.93K |
| Q3 2019 | share | Decrease | -0.16% | -343 shares | -7.68M | $277.4 | 212.74K |
| Q2 2019 | share | Increase | +325.26% | 162.97K shares | 46.12M | $313 | 213.08K |
| Q1 2019 | share | Increase | +548.06% | 42.37K shares | 17.68M | $410.62 | 50.10K |
| Q4 2018 | share | Increase | +4.25% | 315 shares | -109K | $373.5 | 7.73K |
| Q3 2018 | share | Increase | +10.06% | 678 shares | 671K | $404.04 | 7.41K |
| Q2 2018 | share | Decrease | -3.99% | -280 shares | -313K | $344.99 | 6.73K |
| Q1 2018 | share | 0.00% | 0 shares | 0 | $344.36 | 7.01K | |
| Q4 2017 | share | Decrease | -0.31% | -22 shares | -509K | $375.96 | 7.01K |
| Q3 2017 | share | Decrease | -13.66% | -1.11K shares | -12K | $447.12 | 7.04K |
| Q2 2017 | share | 0.00% | 0 shares | 0 | $491.14 | 8.15K | |
| Q1 2017 | share | Decrease | -6.71% | -587 shares | -49K | $387.51 | 8.15K |
| Q4 2016 | share | Increase | +33.69% | 2.20K shares | 580K | $367.09 | 8.74K |
| Q3 2016 | share | Increase | +3.33% | 211 shares | 419K | $402.02 | 6.53K |
| Q2 2016 | share | Increase | +14.99% | 825 shares | 226K | $349.23 | 6.32K |
| Q1 2016 | share | Decrease | -27.75% | -2.11K shares | -2.15M | $360.44 | 5.50K |